why choose us

First received: September 15, 2023

Clinical Trial: The PEERLESS II Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pulmonary Embolism

Study Type: INTERVENTIONAL


Official Title: PEERLESS II: RCT of FlowTriever vs. Anticoagulation Alone in Pulmonary Embolism

Brief Summary: This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation compared to anticoagulation alone for intermediate-risk acute PE.

Read more